Resources and Media
June 26, 2024
Published by lixte-biotech on June 26, 2024
Categories
By Mary C. Clark, Rongze Olivia Lu, Winson S. Ho, Matheus Henrique Dias, René Bernards, […]
June 10, 2024
Published by lixte-biotech on June 10, 2024
Categories
By Matheus Henrique Dias, Chrysa Papagianni, Rene Bernards Volume 42, Issue 6, 10 June 2024, […]
May 1, 2024
Published by lixte-biotech on May 1, 2024
Categories
Lixte’s CEO Bas van der Baan presented at MedInvest Biotech and Pharma Conference, April 3-4, […]
April 30, 2024
Published by lixte-biotech on April 30, 2024
Categories
Research Highlight | Published: 30 April 2024 Targeted Therapies | By Anna Dart Many […]
April 11, 2024
Published by lixte-biotech on April 11, 2024
Categories
First in Human Episode #59 featuring Bas van der Baan Join as we dive deep […]
March 20, 2024
Published by lixte-biotech on March 20, 2024
Categories
LIXTE Biotechnology Holdings Provides Update on Progress with Proprietary LB-100 Compound to Enhance Chemotherapy and […]
February 5, 2024
Published by lixte-biotech on February 5, 2024
Categories
Pasadena-based pharmaceutical company Lixte Biotechnology Holdings Inc.’s new chief executive is also charting a new […]
December 21, 2023
Published by lixte-biotech on December 21, 2023
Categories
Researchers at the National Institute of Health as well as the Netherlands Cancer Institute and […]